Invivyd

IVVDNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$218.010 M

$0.74 +12.29%

Close of 7 Aug 2026

Revenue

$53.4M

#2720 by revenue

Earnings

-$52.5M

Loss-making

Shares outstanding

294,607,452

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#92Protara TherapeuticsTARA$231.6M
#93CompugenCGEN$227.9M
#94InvivydIVVD$218.0M
#95Protalix BioTherapeuticsPLX$198.2M
#96AlectorALEC$197.6M

Where these numbers come from

Share counts and financials for Invivyd are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.